ACSL4 Expression Is Associated With CD8+ T Cell Infiltration and Immune Response in Bladder Cancer

Código QR

ACSL4 Expression Is Associated With CD8+ T Cell Infiltration and Immune Response in Bladder Cancer

ObjectiveThis study aimed to explore the role of ACSL4 in CD8+ T cell tumor infiltration and outcomes of bladder cancer (BLCA) patients after immunotherapy.MethodsThe correlation between ACSL4 expression and tumor infiltration of immune cells was analyzed using the Tumor Immune Estimation Resource d...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Wenjie Luo, Jin Wang, Xiaoyan Dai, Hailiang Zhang, Yuanyuan Qu, Wenjun Xiao, Dingwei Ye, Yiping Zhu
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	bladder cancer immune checkpoint ACSL4 CD8+ T cell immunotherapy Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/81c0569b231a4ea887f9311cddf1f68d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Neoadjuvant Therapy Using Checkpoint Inhibitors before Radical Cystectomy for Muscle Invasive Bladder Cancer: A Systematic Review
por: Hadi SHSM, et al.
Publicado: (2021)

A review on the evolution of immunotherapy in bladder carcinoma
por: Milena Gulinac, et al.
Publicado: (2020)

Avelumab as neoadjuvant therapy in patients with urothelial non-metastatic muscle invasive bladder cancer: a multicenter, randomized, non-comparative, phase II study (Oncodistinct 004 - AURA trial)
por: Nieves Martinez Chanza, et al.
Publicado: (2021)

LncRNA RP11-89 facilitates tumorigenesis and ferroptosis resistance through PROM2-activated iron export by sponging miR-129-5p in bladder cancer
por: Wenjie Luo, et al.
Publicado: (2021)

DNA Methylation Modification Map to Predict Tumor Molecular Subtypes and Efficacy of Immunotherapy in Bladder Cancer
por: Fangdie Ye, et al.
Publicado: (2021)

Targeting Tumor-Associated Macrophages in Cancer Immunotherapy
por: Amy J. Petty, et al.
Publicado: (2021)

Comprehensive analysis of CXCL12 expression reveals the significance of inflammatory fibroblasts in bladder cancer carcinogenesis and progression
por: YiHeng Du, et al.
Publicado: (2021)

Advances in Immunotherapy and the TGF-β Resistance Pathway in Metastatic Bladder Cancer
por: David J. Benjamin, et al.
Publicado: (2021)

5mC regulator-mediated molecular subtypes depict the hallmarks of the tumor microenvironment and guide precision medicine in bladder cancer
por: Jiao Hu, et al.
Publicado: (2021)

Comprehensive Analysis of CPA4 as a Poor Prognostic Biomarker Correlated with Immune Cells Infiltration in Bladder Cancer
por: Chengcheng Wei, et al.
Publicado: (2021)

Cancer Vaccines and Immunotherapy for Tumor Prevention and Treatment
por: Jagmohan Singh, et al.
Publicado: (2021)

PD-L1 expression in Xp11.2 translocation renal cell carcinoma: Indicator of tumor aggressiveness
por: Kun Chang, et al.
Publicado: (2017)

Epigenetic Priming of Bladder Cancer Cells With Decitabine Increases Cytotoxicity of Human EGFR and CD44v6 CAR Engineered T-Cells
por: Camilla M. Grunewald, et al.
Publicado: (2021)

Current Progress and Future Perspectives of Immune Checkpoint in Cancer and Infectious Diseases
por: Xin Cai, et al.
Publicado: (2021)

Thulium Laser Resection of Bladder Tumors vs. Conventional Transurethral Resection of Bladder Tumors for Intermediate and High Risk Non-Muscle-Invasive Bladder Cancer Followed by Intravesical BCG Immunotherapy
por: Zheng Liu, et al.
Publicado: (2021)

A Novel Immune-Gene Pair Signature Revealing the Tumor Microenvironment Features and Immunotherapy Prognosis of Muscle-Invasive Bladder Cancer
por: Xiaonan Zheng, et al.
Publicado: (2021)

Leptin expression is substantially correlated with prognosis of urinary bladder carcinoma
por: Mohamad Nidal Khabaz, et al.
Publicado: (2021)

Global, regional, and national burden of kidney, bladder, and prostate cancers and their attributable risk factors, 1990–2019
por: Hao Zi, et al.
Publicado: (2021)

Flexible cystoscopy can improve anxiety and subjective feelings of bladder cancer patients during follow-up
por: Jie Gao, et al.
Publicado: (2020)

Tumor-Associated Mast Cells in Urothelial Bladder Cancer: Optimizing Immuno-Oncology
por: Hae Woong Choi, et al.
Publicado: (2021)

Progress in the Application of Immune Checkpoint Inhibitor-Based Immunotherapy for Targeting Different Types of Colorectal Cancer
por: Rui He, et al.
Publicado: (2021)

Siglec-7 May Limit Natural Killer Cell–mediated Antitumor responses in Bladder Cancer Patients
por: Sulayman Benmerzoug, et al.
Publicado: (2021)

Efficient intravesical therapy of bladder cancer with cationic doxorubicin nanoassemblies
por: Jin X, et al.
Publicado: (2016)

En-bloc resection of urinary bladder tumour – a prospective controlled multicentre observational study
por: Sławomir Poletajew, et al.
Publicado: (2020)

RNA N6‐methyladenosine modification in the lethal teamwork of cancer stem cells and the tumor immune microenvironment: Current landscape and therapeutic potential
por: Zhihui Zhang, et al.
Publicado: (2021)

Melanoma metastasis to the bladder: A case report
por: Raj A. Kumar, et al.
Publicado: (2022)

CTLA-4 blockade in the treatment of colorectal cancer with microsatellite instability
por: Diana Russo, et al.
Publicado: (2021)

CD122-targeted interleukin-2 and αPD-L1 treat bladder cancer and melanoma via distinct mechanisms, including CD122-driven natural killer cell maturation
por: Ryan M Reyes, et al.
Publicado: (2021)

Persistent Response to a Combination Treatment Featuring a Targeted Agent and an Immune Checkpoint Inhibitor in a Patient With Collecting Duct Renal Carcinoma: A Case Report and Literature Review
por: Weimin Zhou, et al.
Publicado: (2021)

Low TIM3 expression indicates poor prognosis of metastatic prostate cancer and acts as an independent predictor of castration resistant status
por: Junlong Wu, et al.
Publicado: (2017)

Neurogenic Bladder Dysfunction in Cancer Patients after Operations on the Pelvic Organs
por: V. F. Onopko, et al.
Publicado: (2019)

Clinicopathological study of gall bladder cancer and its relationship with gall stones
por: R Poudel, et al.
Publicado: (2016)

Models based on nucleic acid methylation regulators will contribute to facilitating cancer precision medicine
por: Wen Zhang
Publicado: (2021)

OLFML2B Is a Robust Prognostic Biomarker in Bladder Cancer Through Genome-Wide Screening: A Study Based on Seven Cohorts
por: Jiaxing Lin, et al.
Publicado: (2021)

Longitudinal impact of bladder cancer diagnosis on common psychiatric disorders
por: Ian J. Cooke, et al.
Publicado: (2021)

Combined Assessment of the Tumor–Stroma Ratio and Tumor Immune Cell Infiltrate for Immune Checkpoint Inhibitor Therapy Response Prediction in Colon Cancer
por: Cor J. Ravensbergen, et al.
Publicado: (2021)

Immunotherapy in Medulloblastoma: Current State of Research, Challenges, and Future Perspectives
por: Marije J. Voskamp, et al.
Publicado: (2021)

Primary bladder amyloidosis mimicking bladder cancer complicated by bladder rupture: A case report
por: Rayan M. Sibira, et al.
Publicado: (2021)

Immunotherapy for HER2-positive breast cancer: recent advances and combination therapeutic approaches
por: Ayoub NM, et al.
Publicado: (2019)

Nanosonosensitizer-Augmented Sonodynamic Therapy Combined with Checkpoint Blockade for Cancer Immunotherapy
por: Lin X, et al.
Publicado: (2021)